Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivors.

Lukas Motloch; Peter Jirak; Moritz Mirna; Lukas Fiedler; Paruir A Davtyan; Irina A Lakman; Diana F Gareeva; Anton V Tyurin; Ruslan M Gumerov; Simon T Matskeplishvili; Valentin N Pavlov; Benzhi Cai; Kristen Kopp; Albert Topf; Uta Hoppe; Rudin Pistulli; Naufal S Zagidullin

doi:10.3389/fcvm.2022.916156

Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivors.

Lukas Motloch^* (First author), Peter Jirak (Co-author), Moritz Mirna (Co-author), Lukas Fiedler, Paruir A Davtyan, Irina A Lakman, Diana F Gareeva, Anton V Tyurin, Ruslan M Gumerov, Simon T Matskeplishvili, Valentin N Pavlov, Benzhi Cai, Kristen Kopp (Co-author), Albert Topf (Co-author), Uta Hoppe (Co-author), Rudin Pistulli, Naufal S Zagidullin

^*Corresponding author for this work

Department of Internal Medicine II - Division of Cardiology

Research output: Contribution to journal › Original Article (Journal) › peer-review

5 Citations (Web of Science)

Original language	English
Pages (from-to)	916156
Journal	Frontiers in Cardiovascular Medicine
Volume	9
DOIs	https://doi.org/10.3389/fcvm.2022.916156
Publication status	Published - 2022

Keywords

DISEASE

Access to Document

10.3389/fcvm.2022.916156

Cite this

Motloch, L., Jirak, P., Mirna, M., Fiedler, L., Davtyan, P. A., Lakman, I. A., Gareeva, D. F., Tyurin, A. V., Gumerov, R. M., Matskeplishvili, S. T., Pavlov, V. N., Cai, B., Kopp, K., Topf, A., Hoppe, U., Pistulli, R., & Zagidullin, N. S. (2022). Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivors. Frontiers in Cardiovascular Medicine, 9, 916156. https://doi.org/10.3389/fcvm.2022.916156

@article{cc8e73d4234c4174883a094bce3ec6ef,

title = "Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivors.",

keywords = "DISEASE",

author = "Lukas Motloch and Peter Jirak and Moritz Mirna and Lukas Fiedler and Davtyan, {Paruir A} and Lakman, {Irina A} and Gareeva, {Diana F} and Tyurin, {Anton V} and Gumerov, {Ruslan M} and Matskeplishvili, {Simon T} and Pavlov, {Valentin N} and Benzhi Cai and Kristen Kopp and Albert Topf and Uta Hoppe and Rudin Pistulli and Zagidullin, {Naufal S}",

note = "Hoppe, Uta; Jirak, Peter; Kopp, Kristen; Mirna, Moritz; Motloch, Lukas, Topf, Albert; Fiedler, Lukas: Clinic II for Internal Medicine, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria***Department of Internal Medicine, Cardiology, Nephrology and Intensive Care Medicine, Hospital Wiener Neustadt, Wiener Neustadt, Austria ",

year = "2022",

doi = "10.3389/fcvm.2022.916156",

language = "English",

volume = "9",

pages = "916156",

journal = "Frontiers in Cardiovascular Medicine",

issn = "2297-055X",

publisher = "Frontiers Media Sa",

}

Motloch, L, Jirak, P, Mirna, M, Fiedler, L, Davtyan, PA, Lakman, IA, Gareeva, DF, Tyurin, AV, Gumerov, RM, Matskeplishvili, ST, Pavlov, VN, Cai, B, Kopp, K, Topf, A, Hoppe, U, Pistulli, R & Zagidullin, NS 2022, 'Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivors.', Frontiers in Cardiovascular Medicine, vol. 9, pp. 916156. https://doi.org/10.3389/fcvm.2022.916156

Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivors. / Motloch, Lukas (First author); Jirak, Peter (Co-author); Mirna, Moritz (Co-author) et al.
In: Frontiers in Cardiovascular Medicine, Vol. 9, 2022, p. 916156.

Research output: Contribution to journal › Original Article (Journal) › peer-review

TY - JOUR

T1 - Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivors.

AU - Motloch, Lukas

AU - Jirak, Peter

AU - Mirna, Moritz

AU - Fiedler, Lukas

AU - Davtyan, Paruir A

AU - Lakman, Irina A

AU - Gareeva, Diana F

AU - Tyurin, Anton V

AU - Gumerov, Ruslan M

AU - Matskeplishvili, Simon T

AU - Pavlov, Valentin N

AU - Cai, Benzhi

AU - Kopp, Kristen

AU - Topf, Albert

AU - Hoppe, Uta

AU - Pistulli, Rudin

AU - Zagidullin, Naufal S

N1 - Hoppe, Uta; Jirak, Peter; Kopp, Kristen; Mirna, Moritz; Motloch, Lukas, Topf, Albert; Fiedler, Lukas: Clinic II for Internal Medicine, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria***Department of Internal Medicine, Cardiology, Nephrology and Intensive Care Medicine, Hospital Wiener Neustadt, Wiener Neustadt, Austria

PY - 2022

Y1 - 2022

KW - DISEASE

U2 - 10.3389/fcvm.2022.916156

DO - 10.3389/fcvm.2022.916156

M3 - Original Article (Journal)

C2 - 35966512

SN - 2297-055X

VL - 9

SP - 916156

JO - Frontiers in Cardiovascular Medicine

JF - Frontiers in Cardiovascular Medicine

ER -